The differential expression of CD160 and CD80 in the two groups was consistent with the bioinformatics analysis results of Feng et al. Anti-PD-1-CTLA4 has a positive effect in combinatorially combating PCa [35]. This evidence concerns the gene CTLA4 and posterior cortical atrophy.